Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Hopes that cancer drug will benefit Glivec-resistant patients
Company's growth so far this year has been three times the industry rate
Company optimistic about future sales despite spate of patent expiries
After a slow start, Prevnar growth gathers speed
Promising results and cheaper administration make drug an attractive first-line option
AstraZeneca poised to exploit its cancer drug's market lead
Risk management plan put in place to overcome dangerous side effects
Deal represents AstraZeneca's third major collaboration in 12 months
Sales growth rate of 23% in 2005 set to increase even further
But cost could could prove a major obstacle
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches